Product Information

AMLODIPINE-VALSARTAN 10-320 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4495 per EA under NDC 00378172493. Its NADAC has been published 591 times since Apr 29, 2015.

FDA first approved this application on Mar 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 10-320 MG

AMLODIPINE AND VALSARTAN
$0.4495per EA

Strength

10; 320 mg/1; mg/1

NDC

00378172493

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090483

FDA Approved

3/30/2015

TE Code

AB

On Market Since

3/30/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 10-320 MG has been published 591 times since Apr 29, 2015, and over the history we have for it it has declined 92.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4495 per EA
All-time high$6.1152 (May 13, 2015)
All-time low$0.4495 (Aug 19, 2026)
52-week high$0.6623
52-week low$0.4495
Median price$0.6449
Average price$0.7104
Largest weekly change-69.1% (Jul 22, 2015)
Weeks tracked591
Tracking sinceApr 29, 2015

Price History

1W

-6.3%

1M

-6.3%

3M

-27.5%

6M

-30.3%

1Y

-31.8%

3Y

-37.9%

5Y

-30.5%

All

-92.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the AMLODIPINE AND VALSARTAN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 10-320 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-320 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.4495 per EA (NDC 00378172493), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 10-320 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-320 MG has declined 92.6%. It has been tracked across 591 weekly CMS publications since Apr 29, 2015.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-320 MG?

Since Apr 29, 2015, the NADAC for AMLODIPINE-VALSARTAN 10-320 MG has ranged from a low of $0.4495 (Aug 19, 2026) to a high of $6.1152 (May 13, 2015), with a median of $0.6449 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-320 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 10-320 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN 10-320 MG?

AMLODIPINE-VALSARTAN 10-320 MG (NDC 00378172493) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.